Medical Affairs teams face persistent challenges to be the interface between their company, product, KOL external experts, and prescribers. Evolving restrictions for compliance and limited commercial resources have placed greater emphasis onto Medical Affairs teams. BioPharma has greatly restricted resources and must rely greatly on these teams to communicate medical information and promote value. This summit focuses on strategies for engagement and success for medical affairs organizations to meet current and future organization needs.
The World Congress Summit - Leverage EHRs for Prescriber EngagementWorldCongress
This World Congress EHR Summit focuses on improving patient access by focusing on Health Information Technology and Health Information Management since the demand for Personal Health Management and Health Information Exchanges through ePrescribing and EHR portals has increased. Leverage Federal Quality Initiatives by supporting Meaningful Use through Electronic Health Records (EHRs)
World Congress Patient Engagement SummitWorldCongress
Patient Engagement has long been a buzzword for clinicians and health care organizations — however true engagement strategies and patient-centered care designs have fallen flat for many organizations or become simply a theoretical vision. In order to meet Meaningful Use standards and most importantly improve clinical outcomes for patients, providers must actually engage and incorporate patients into the equation for better health outcomes.
Join us at the World Congress Patient Engagement Summit as we leave behind theory and bring about actionable change with actionable solutions to engage patients and move the needle on clinical outcomes and community health. Collaborate with multiple stakeholders and learn how some of the nation’s most innovation hospitals and health systems are engaging the most complex and vulnerable patient populations through communication strategies, community involvement, and technology.
http://www.worldcongress.com/events/HL14021/
The World Congress Summit - Leverage EHRs for Prescriber EngagementWorldCongress
This World Congress EHR Summit focuses on improving patient access by focusing on Health Information Technology and Health Information Management since the demand for Personal Health Management and Health Information Exchanges through ePrescribing and EHR portals has increased. Leverage Federal Quality Initiatives by supporting Meaningful Use through Electronic Health Records (EHRs)
World Congress Patient Engagement SummitWorldCongress
Patient Engagement has long been a buzzword for clinicians and health care organizations — however true engagement strategies and patient-centered care designs have fallen flat for many organizations or become simply a theoretical vision. In order to meet Meaningful Use standards and most importantly improve clinical outcomes for patients, providers must actually engage and incorporate patients into the equation for better health outcomes.
Join us at the World Congress Patient Engagement Summit as we leave behind theory and bring about actionable change with actionable solutions to engage patients and move the needle on clinical outcomes and community health. Collaborate with multiple stakeholders and learn how some of the nation’s most innovation hospitals and health systems are engaging the most complex and vulnerable patient populations through communication strategies, community involvement, and technology.
http://www.worldcongress.com/events/HL14021/
This presentation focuses on SWOT analysis. The definition of a SWOT analysis and its purpose is covered. The presenter preforms a SWOT analysis on the American health retail sector and ends with recommendations and a summery.
A presentation on sustainability of Pfizer using Triple Bottom Line.
This was researched and presented by my colleagues and I as part of the Accounting Issues module.
The 3rd Physician Liaison Summit – Chicago provides real-life examples and strategies for liaisons to strengthen their programs, capture referrals, and increase hospital/health system revenue. This meeting provides proven methods and best practices from your local peers who are leaders in the field as they share insight and tips on how to adapt and implement these same methods into your hospital/health system. Conveniently located, this Midwest Summit is a must-attend meeting for all physician liaisons – whether new to the role, or in a leadership position with years of experience.
Discover how to use analytics to drive objectives and results.
Establish value both internally and in referrers' offices.
Prepare for the future of the liaison role.
http://www.worldcongress.com/events/HL14020/
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices
The current structure of medical education emphasizes pedagogy related to the physician-patient relationship, and thus advocacy opportunities at this level. Patient and professional Advocacy Groups are important to the process of educating the marketplace on new therapies. Strong relationships with advocacy groups are important for educating the public on socially-sensitive conditions and treatment options.
Best Practices, LLC's study identifies effective practices in patient advocacy group collaboration and relationship management. This study also examines ideal structures and skill sets for pharma groups that deal with advocacy groups and emerging trends and challenges in patient advocacy.
Download Full Report: http://bit.ly/2evZ0AE
Delivering on the Vision: Keys to Achieving Breakthrough Operational Performa...Huron Consulting Group
In this presentation, Daniel May, Huron Healthcare managing director, and Mark Mullarkey, Texas Children’s Hospital Senior Vice President, share: insights into tracking the initiative’s progress, strategies for engaging physicians, and real-world lessons learned from the initiative.
At the end of this 90 minute session patient/ family/ advisors/ champions as well as health providers/ leaders/ authorities will leave with at least one practical idea to apply to patient advisor training as a result of their increased understanding of:
Current training programs and models in use across Canada
Training needs of patient advisors at different system levels
Gaps in training needs and ideas on how to fill them
Available supporting resources and leading practices
The Powerful and Evolving Role ofPatient Advocacy Groups in Orphan Drug Deve...PremierResearch_
Want to chat? Set up time to speak here: http://info.premier-research.com/TalktoPremier
A major goal of patient advocacy groups is to address the unmet needs of patients with cancer or rare diseases by providing access to the most effective drugs. In recent years, patient advocacy groups have expanded their influence over the drug development continuum from discovery to approval to market entry. Many groups directly fund, help design, or recruit patients to participate in clinical trials.
This webinar reviews the history of patient advocacy groups in advancing clinical research and examines the evolution of their role in light of recent and pending legislative and regulatory changes in the United States and European Union. Included is a discussion of how patient advocacy groups and industry can join to respond most effectively to these anticipated changes. Presenters are Susan Stein, MPH, a member of the Board of Directors of worldwide patient advocate umbrella organization Global Genes, and Juliet Moritz, MPH, Executive Director of Strategic Drug Development for Rare Diseases at Premier Research.
How to Keep Your Medical Staff Close and Your Referring Physicians Closer glcbaby
Physician referrals remain an important driver of patient volume, but the relationship with referring providers is inherently tricky. This past April, Paula Frey, GLC's Senior Vice President of Marketing & Client Services, co-presented ”How to Keep Your Medical Staff Close and Your Referring Physicians Closer,” with Josie Aguirre, Director of Physician Relations and Communications at the University of Michigan Health System. The presentation took place at the 2013 Association of American Medical Colleges Group Institutional Advancement conference in Hollywood, Florida.
Learn more about Univ. of Michigan Healthy System's Colleagues in Care custom magazine program: http://glcdelivers.com/our-work/university-of-michigan/
Medical Affairs, as a function, sits at a crossroads in the pharmaceutical industry. The department is expected to act as a bridge between the commercial and scientific arms of an organization. Medical Affairs is further tasked with being the conduit of information between the company and external stakeholders, bringing efficacy and safety data to the medical community as well as gathering insights from the medical community to share internally. All responsibilities must be undertaken while keeping in mind strict regulatory controls and ensuring that medical data are interpreted appropriately.
ISR has designed this report to be used as a benchmarking tool for companies to compare their Medical Affairs functions to those of Top 50 pharmaceutical organizations.
See more: http://bit.ly/medaffairs
This presentation focuses on SWOT analysis. The definition of a SWOT analysis and its purpose is covered. The presenter preforms a SWOT analysis on the American health retail sector and ends with recommendations and a summery.
A presentation on sustainability of Pfizer using Triple Bottom Line.
This was researched and presented by my colleagues and I as part of the Accounting Issues module.
The 3rd Physician Liaison Summit – Chicago provides real-life examples and strategies for liaisons to strengthen their programs, capture referrals, and increase hospital/health system revenue. This meeting provides proven methods and best practices from your local peers who are leaders in the field as they share insight and tips on how to adapt and implement these same methods into your hospital/health system. Conveniently located, this Midwest Summit is a must-attend meeting for all physician liaisons – whether new to the role, or in a leadership position with years of experience.
Discover how to use analytics to drive objectives and results.
Establish value both internally and in referrers' offices.
Prepare for the future of the liaison role.
http://www.worldcongress.com/events/HL14020/
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices
The current structure of medical education emphasizes pedagogy related to the physician-patient relationship, and thus advocacy opportunities at this level. Patient and professional Advocacy Groups are important to the process of educating the marketplace on new therapies. Strong relationships with advocacy groups are important for educating the public on socially-sensitive conditions and treatment options.
Best Practices, LLC's study identifies effective practices in patient advocacy group collaboration and relationship management. This study also examines ideal structures and skill sets for pharma groups that deal with advocacy groups and emerging trends and challenges in patient advocacy.
Download Full Report: http://bit.ly/2evZ0AE
Delivering on the Vision: Keys to Achieving Breakthrough Operational Performa...Huron Consulting Group
In this presentation, Daniel May, Huron Healthcare managing director, and Mark Mullarkey, Texas Children’s Hospital Senior Vice President, share: insights into tracking the initiative’s progress, strategies for engaging physicians, and real-world lessons learned from the initiative.
At the end of this 90 minute session patient/ family/ advisors/ champions as well as health providers/ leaders/ authorities will leave with at least one practical idea to apply to patient advisor training as a result of their increased understanding of:
Current training programs and models in use across Canada
Training needs of patient advisors at different system levels
Gaps in training needs and ideas on how to fill them
Available supporting resources and leading practices
The Powerful and Evolving Role ofPatient Advocacy Groups in Orphan Drug Deve...PremierResearch_
Want to chat? Set up time to speak here: http://info.premier-research.com/TalktoPremier
A major goal of patient advocacy groups is to address the unmet needs of patients with cancer or rare diseases by providing access to the most effective drugs. In recent years, patient advocacy groups have expanded their influence over the drug development continuum from discovery to approval to market entry. Many groups directly fund, help design, or recruit patients to participate in clinical trials.
This webinar reviews the history of patient advocacy groups in advancing clinical research and examines the evolution of their role in light of recent and pending legislative and regulatory changes in the United States and European Union. Included is a discussion of how patient advocacy groups and industry can join to respond most effectively to these anticipated changes. Presenters are Susan Stein, MPH, a member of the Board of Directors of worldwide patient advocate umbrella organization Global Genes, and Juliet Moritz, MPH, Executive Director of Strategic Drug Development for Rare Diseases at Premier Research.
How to Keep Your Medical Staff Close and Your Referring Physicians Closer glcbaby
Physician referrals remain an important driver of patient volume, but the relationship with referring providers is inherently tricky. This past April, Paula Frey, GLC's Senior Vice President of Marketing & Client Services, co-presented ”How to Keep Your Medical Staff Close and Your Referring Physicians Closer,” with Josie Aguirre, Director of Physician Relations and Communications at the University of Michigan Health System. The presentation took place at the 2013 Association of American Medical Colleges Group Institutional Advancement conference in Hollywood, Florida.
Learn more about Univ. of Michigan Healthy System's Colleagues in Care custom magazine program: http://glcdelivers.com/our-work/university-of-michigan/
Medical Affairs, as a function, sits at a crossroads in the pharmaceutical industry. The department is expected to act as a bridge between the commercial and scientific arms of an organization. Medical Affairs is further tasked with being the conduit of information between the company and external stakeholders, bringing efficacy and safety data to the medical community as well as gathering insights from the medical community to share internally. All responsibilities must be undertaken while keeping in mind strict regulatory controls and ensuring that medical data are interpreted appropriately.
ISR has designed this report to be used as a benchmarking tool for companies to compare their Medical Affairs functions to those of Top 50 pharmaceutical organizations.
See more: http://bit.ly/medaffairs
Medical Affairs Resources, Structures, and Trends (UPDATE) - Report SummaryBest Practices
The Update to the wildly popular Medical Affairs Resources, Structures, and Trends research from 2009 is ready! Contains linear data and new segmentation for emerging markets.
Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency. As such, forward-looking biopharmaceutical executives are beginning to evaluate Medical Affairs operations to ensure that the vital organization is appropriately structured and resourced to operate effectively in the current environment.
This Best Practices, LLC study explores how U.S. and global biopharmaceutical companies are structuring and managing their Medical Affairs organizations today. The study also examines recent trends in budget and staffing resources, key challenges and top success factors for the function.
The report is based on the insights of 68 Medical Affairs executives and managers at 50 leading global companies. The benchmark class in this study consists of a Mature Markets and Emerging Markets Segment. The Mature Market Segment includes 41 participants from pharma and 12 device respondents. The Emerging Markets Segment consists of 15 participants working in India, China, Brazil, and Turkey.
This presentation gives an insight into the membership benefits of Best Practices, LLC’s Medical Affairs Consortium. It also highlights some of the key benchmarks and best practices that emerged from Medical Affairs Consortium.
The Medical Affairs Consortium at Best Practices, LLC provides a dedicated platform to Medical Affairs Leaders to discuss top challenges, develop action oriented solutions, share best practices & lessons learned and explore current and future trends with regards to the Medical Affairs function and its interactions with other critical functions.
Topics for the Medical Affairs Consortium are usually determined by member requests. The Medical Affairs Consortium addresses three key areas:
• Building Strong Medical Affairs Capabilities
• Medical Affairs Launch Support Excellence
• Medical Affairs’ Critical Role in Health Economics & Outcomes Research
Real World Evidence HEOR and Post Approval Studies SummitWorldCongress
This executive level summit explores strategies for innovation in the evolving world of data. Hear from a variety of stakeholder perspectives including industry, regulatory, CRO, and related organizations who will address the key strategies for success in the ever-changing post-marketing environment. The agenda features cutting-edge methods and in-depth case studies that provide pragmatic, real world takeaways. Attend this summit to gain critical insights and collaborate with your peers on the best methods and strategies for post-approval success.
http://www.worldcongress.com/events/PB14019/
Contact center professionals face a number of challenges in the ever changing environment including management of intensifying cost pressures, maintenance and improvement of customer service, operation of globalized centers, and compliance with the changing regulatory environment. This summit explores innovative communication channels for customer engagement, technologies for cost effectiveness, and innovative strategies to stay at the front of the curve. Cross-industry perspectives provide a well-rounded and unique perspective on cutting edge technologies and strategies for contact center optimization.
http://www.worldcongress.com/events/PB14018/
This conference offers delegates an in-depth view of the latest initiatives that are simplifying and improving the clinical trial experience for the patient through data-sharing and setting industry standards. Leading individuals from biopharma partnerships and consortia come together to share the results and impact of their projects, as well as insights on areas ripe for future collaboration. The conference provides delegates with opportunities to learn from one another in regard to what works now and a forum to discuss how to leverage and build on collective experiences to advance innovation across the wider community.
We discuss:
Responsible Clinical Trials Data Sharing – Protecting Intellectual Property While Enabling Public Access to Data.
The Project Data Sphere Initiative – A New Data Sharing and Analytics Model for Cancer Research.
Clinical Trials Transformation Initiative – Advancing Central IRBs, IND Safety and a Quality by Design Approach to Clinical Trial Operations.
Lessons Learned from Pilot Studies on Risk-Based Monitoring Methodology to Identify Risk and Ensure Data Quality.
A Model to Create, Share, and Re-Use Structured Content throughout the Clinical Trial Life Cycle – The Sanofi-TransCelerate Collaboration.
CISCRP Recommendations – Communicate Trial Results to Participants to Improve Experience and Build Support for the Clinical Research Enterprise.
http://www.worldcongress.com/events/PB14014/
The New Orleans BioInnovation Center presents the annual Innovation Louisiana Conference on forming, funding, and growing a bioscience startup featuring national industry experts and investors. Through panel discussions and keynotes by national experts, the conference educates life science entrepreneurs, university researchers, students, and the business community on technology innovation issues. Get educated and inspired as you work to move breakthroughs from the lab to the market. Don’t miss this important opportunity to learn about key issues from finding funding for development and commercialization to successfully introducing innovations in a clinical setting.
International and regional experts coming together
to discuss strategies and opportunities in the Medical
Affairs function
• Unique insights and case studies on experiences in
the Asia market, successful programmes and best
practices
• Detailed and practical workshop to complement
your learning and networking experience
Year after year, technology has played a role in changing the way that health care is delivered. Now in 2014, as technology continues to advance, consumers are demanding more convenient and cost effective care through increased use of mHealth and Telehealth. The mHealth + Telehealth World 2014 is must attend event for health care executives interested in learning how to most efficiently utilize Telehealth programs and mHealth practices to improve patient outcomes by promoting interoperability, sustainability, provider interest, and consumer engagement. Hear case studies, understand the ROI, and discuss ways to address critical issues – including licensing and security issues – of digital health practices.
http://www.worldcongress.com/events/HL14028/
Stage-gate Healthcare Initiatives • Strategise Innovative Models of Care • Assess Expense Management • Evaluate Partnerships in Managed Care • Measure Innovation • Improve Population Health
Similar to BioPharma Medical Affairs Congress, West Coast (20)
3rd Annual Summit to Improve Adherence and Enhance Patient Engagement WorldCongress
Medication non-adherence is a $300 billion dollar national public health issue. Cross-industry stakeholders must address this system-wide challenge by sharing research, innovations, and strategies for improved outcomes. This summit is a must-attend event for executives interested in multi-disciplinary collaboration to drive adherence while offering innovative scalable patient engagement and adherence strategies. Leading industry payers, pharma, providers, pharmacists, patients, and technology providers convene to resolve the adherence issue and drive improved health outcomes.
Improve Adherence and Enhance Patient Engagement (Preview)WorldCongress
Medication non-adherence is a $300 billion dollar national public health issue. Cross-industry stakeholders must address this system-wide challenge by sharing research, innovations, and strategies for improved outcomes. This summit is a must-attend event for executives interested in multi-disciplinary collaboration to drive adherence while offering innovative scalable patient engagement and adherence strategies. Leading industry payers, pharma, providers, pharmacists, patients, and technology providers convene to resolve the adherence issue and drive improved health outcomes.
The 3rd Annual Global Pharmaceutical and Medical Meetings SummitWorldCongress
We are excited to announce the launch of the 3rd Annual Global Pharmaceutical and Medical Meetings Summit ™. The boutique-like Summit gathers senior pharmaceutical, biotech, medical device and healthcare meeting executives for empowering ROI-driven conversations about the industry’s biggest opportunities. Those conversations are amplified in a way no other event can be through ongoing networking and shared best practices.
As usual, World Congress commits to a 50/50 or better ratio of Meeting executive and Solution Providers.
The World Congress Summit on Risk-Based Monitoring and the Quality Risk Manag...WorldCongress
This Summit offers pharmaceutical and medical device delegates concrete examples of how to build a framework and methodology for a risk-based monitoring (RBM) program that is part of an overall risk management approach to study planning and oversight. One of the biggest challenges of implementation is overcoming resistance to change as no organization wants to be the first. For that reason, Summit faculty share change management strategies for people, processes, and technology that led to the effective implementation of their RBM programs. The Site’s perspective, assessing readiness for change and providing support during the change process must not be overlooked. Strategies to partner with Sites to achieve stronger connectivity will also be discussed.
Insurer's Customer Experience and Member Retention SummitWorldCongress
So you enrolled some of the 8 million health insurance consumers that were granted access to care under the Affordable Care Act and a number of other members during the inaugural AEP… Now what?
Topics include:
A focus on consumer experience as a differentiator in the market.
Shared sessions with providers surrounding member health, experience, and strategies to improve overall health outcomes through additive engagement programs for your members.
Strategies to retrain and revolutionize your call center operations to increase touch points with members, offer reform and policy advice, and include a sales aspect to persuade members to stay with your organization.
Advancements in technology that allow carriers to identify members at risk of cancelling their policies, and ways to personalize retention communications to prevent these cancelations.
Tips to navigate the rapidly changing post-reform landscape, and adapt to fluctuating legislation provisions and mandate extensions.
http://www.worldcongress.com/events/HW14084/
The World Congress Summit on Patient Solution Services and Hub Design WorldCongress
Due to elevated needs for value-based and cost-effective treatments, bio/pharma has the opportunity to implement patient assistance and hub programs to support the patient journey. Assess strategies to ensure effective patient adherence, customer satisfaction, brand loyalty, and additional prescriber touch points by navigating reimbursement programs.
Understand ACA implications on opportunities and challenges of patient solution services.
Integrate support with nonprofit patient organizations and copay assistance foundations.
Break down regulatory barriers to successful patient engagement.
Benchmark metrics for successful Hubs: Optimize the right Hub design to fit portfolio needs.
Improve speed to therapy through new technologies.
http://www.worldcongress.com/events/PB14011/
The 2014 Health Insurance Exchanges Summit features a timely agenda focused on leveraging current “knowns” and progress to derive practical strategies for successful future participation in HIXs. Health plan executives, state and federal exchange officials, providers, and other policy experts convene to discuss business and operational considerations in a changing marketplace.
http://www.worldcongress.com/events/HL14022/
The 2014 Medicare Summit will feature a comprehensive, timely offering of sessions focused on key issues currently impacting the industry including the Dual Eligible population, ACOs, the sustainable growth rate, Medicare Advantage and star ratings. As the landscape of healthcare policy and reform continues to change at a rapid pace, it is imperative for hospitals, health systems, physicians, administrators, and health plans to stay well-informed so they can remain profitable.
http://www.worldcongress.com/events/HL14026/
Medicaid Expansion has ushered in new challenges for those working in the Medicaid Industry. At the 2014 Medicaid Summit, join Medicaid Directors and industry leaders to discuss solutions to the challenges that are surfacing with Medicaid Expansion. Be a part of the discussions on the Medicaid regulations and access to care and their impact on the Medicaid industry for state operators, providers and Medicaid health plans.
http://bit.ly/MedicaidSummit
THe Employee Well-Being Bootcamp for HR, Benefits and Wellness ProfessionalsWorldCongress
The conversation on employee wellness begins with the fundamentals. Through employer case studies and presentations by forward-thinking employers and industry thought leaders, this meeting delivers a fresh look at the evolution of wellness, innovative initiatives, and building programs founded on reconciling business goals with employee health accountability. Whether you are considering or are in the early stages of crafting the business plan for your employee well-being program, seeking training for new team members, or looking for a refresher, this meeting is ideal for your organization.
http://bit.ly/1p6GO2H
Premium MEAN Stack Development Solutions for Modern BusinessesSynapseIndia
Stay ahead of the curve with our premium MEAN Stack Development Solutions. Our expert developers utilize MongoDB, Express.js, AngularJS, and Node.js to create modern and responsive web applications. Trust us for cutting-edge solutions that drive your business growth and success.
Know more: https://www.synapseindia.com/technology/mean-stack-development-company.html
Building Your Employer Brand with Social MediaLuanWise
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
B2B payments are rapidly changing. Find out the 5 key questions you need to be asking yourself to be sure you are mastering B2B payments today. Learn more at www.BlueSnap.com.
VAT Registration Outlined In UAE: Benefits and Requirementsuae taxgpt
Vat Registration is a legal obligation for businesses meeting the threshold requirement, helping companies avoid fines and ramifications. Contact now!
https://viralsocialtrends.com/vat-registration-outlined-in-uae/
Auditing study material for b.com final year students
BioPharma Medical Affairs Congress, West Coast
1. S av e $ 2 0 0 o r m o re b y reg i ster i n g b y Octo ber 1 7 , 2 0 1 4 !
World Congress Presents the Third Medical Affairs Summit
BioPharma Medical
December 10-11, 2014
Affairs Congress, West Coast
Ensure Value, Compliance, Success, and Growth by Doing More with Less
H i lt on San D i e g o R esort & S pa • San D i ego, C A
With vastly limited resources, BioPharma is faced with the challenge
to excel in a restricted environment. This summit offers a uniquely-dedicated
forum for BioPharma Medical and Clinical Affairs
executives to convene and benchmark strategies for success.
Establish a medical
affairs organization
Msl lifecycle
management
Go global
Msl roles and
evolution
Communicate real
world evidence
Define
compliance
barrier
Specifically
designed for
emerging and
Growing Biotech
companies!
Target
External
outreach
Engagement
The evolving role
of medical affairs
Communication
Cultivate
Outreach
Develop
Internal obstacles
Innovation research
collaboration
Demonstrate Value to
Internal stakeholders
Enhance the impact of
medical affairs with
limited resources
Build high value
medical affairs teams
MSL quality Metrics:
determine Value
KOL
development
External scientific
collaboration
Dennis Decktor,
PhD, MBA
Senior Medical
Director, Lead
Medical Affairs
REGENERON
Kelly Hogan,
PharmD
Medical Director,
Immunology
GRIFOLS
Peter Lee, JD, LLM
Senior Director,
Healthcare
Compliance
PHARMACYCLICS
Nicole H.
Longwell, PhD
National Director,
Medical Science
Liaisons,
Autoimmune
and Rare
Diseases Business
Mallinckrodt
Jeffrey
McCombs, PhD
Director of
Graduate Studies
Schaeffer
Center
for Health
Policy and
Economics, USC
William
Soliman, PhD
Medical Director,
Metabolic
Diseases, Specialty
Care, Medical
Affairs Group
Eisai, Inc.
FEATURED facult y perspecti ves:
Partners: Workshop Organized by:
Sponsor: @wrldhealthcare
#biomsl
To register, please visit www.worldcongress.com/biomsl • Phone: 800-767-9499 • Fax: 781-939-2543 • Email: wcreg@worldcongress.com
2. World Congress Presents the Third Medical Affairs Summit
BioPharma Medical
December 10-11, 2014
Affairs Congress, West Coast
Ensure Value, Compliance, Success, and Growth by Doing More with Less
H i lt on San D i e g o R esort & S pa • San D i ego, C A
Who Should Attend
Heads of Medical Affairs departments
and MSL Directors from small, medium,
and large Biotech manufacturers will
greatly benefit from this uniquely
dedicated summit. Vice Presidents,
Heads, Directors, and Managers from the
following sectors will be in attendance:
• Medical Affairs
• Clinical and Scientific Affairs
• Medical Science Liaison Directors
• Medical Directors
• Chief Medical Officers
• Therapeutic Area Leads
• KOL Development
• Medical Communications
• Medical Information
• Medical Science Liaisons
• HOPE Liaisons
• Clinical Science Liaisons
• Managed Care Liaisons
BioPharma is faced with the challenge to do more
with less at the best value — This is especially true
when it comes to developing and growing successful
Medical Affairs operations. Medical Affairs teams
face persistent challenges to be the interface between
their company, product, KOL external experts, and
prescribers. Evolving restrictions for compliance
and limited commercial resources have placed greater
emphasis onto Medical Affairs teams. Biotech
companies have greatly restricted resources and
must rely greatly on these teams to communicate
medical information and promote value. This summit
focuses on strategies for engagement and success for
biotech medical affairs organizations to meet current
and future organization needs.
WHY YOU SHOULD SPONSOR
POSITION
your company
as a leading
solutions and
service provider
MEET
your market
SHOWCASE
new technology
innovations
INCREASE
brand awareness
GENERATE
leads and new
business
DEVELOP
new and
current client
relationships
Benefit from one-on-one meetings, corporate branding and relationship
building by participating as an active corporate supporter and sponsor.
To inquire about sponsorship and executive networking opportunities, contact:
David Capobianco, Vice President, Business Development, World Congress
781-939-2635 | David.Capobianco@worldcongress.com
To register, please visit www.worldcongress.com/biomsl • Phone: 800-767-9499 • Fax: 781-939-2543 • Email: wcreg@worldcongress.com
3. Day One – Wednesday, December 10, 2014
7:30 am –
8:30 am Workshop Registration and Morning Coffee
Pre- Summit workshops
8:30 am –
11:45 am Workshop: Establish A Medical Affairs Organization —
Set up for Success by Determining When and How to Develop an MSL Team for Deployment
Medical Affairs organizations have critical demands on clinical data deadlines, internal staffing architecture of medical field teams,
and necessity of proper outreach with restricted budgets and resources. This interactive workshop examines critical factors to
identify and methods to establish an ideal action plan for optimal field team recruitment, training, and deployment that best serves
the product lifecycle:
• Establish a timeline that coincides with drug development, product launch, and commercialization
• Work with clinical investigators to disperse data to the scientific community
• Determine the timing of MSL outreach readiness by assessing drug development phases
Workshop Facilitator:
Nicole H. Longwell, PhD
National Director, Medical Science Liaisons,
Autoimmune and Rare Diseases Business
Mallinckrodt
David Jencen, PhD
Principal
Jencen Field Medical Consulting
Workshop Sponsor:
11:45 am –
1:00 pm Lunch on your own / Main Summit Registration
Main Summit
1:00 pm –
1:15 pm Chairperson’s Welcome and Opening Remarks
Sean Turbeville, PhD
Senior Director, Medical and Scientific Affairs
Sunesis (Tentative)
1:15 pm –
2:00 pm Opening Keynote:
The Evolving Role of Medical Affairs in Engagement, Outreach, and Communication
Health care reform has a vast impact on the balance of compliance, engagement, and communication as conducted by medical affairs
teams. Understand the developments and implications on Medical Affairs in the new landscape:
• Understand the commercial and medical implications of reform
• Set up for success by leveraging field advancements and opportunities
• Address quality and payer requirements and effects on medical affairs teams
• Assess benefits of conducting comparative effective research with institutions for enhanced reach
Jeffrey McCombs, PhD
Associate Professor, Director of Graduate Studies, Clinical Pharmacy and Pharmaceutical Economics & Policy
Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California
2:00 pm –
2:45 pm Enhance External Outreach of Medical Affairs for Maximum Uptake
Biotech companies face similar industry limitations as large pharma, coupled with the need to excel in a vastly changing market.
Examine obstacles and opportunities for success including enhanced product promotion, communication, engagement, and uptake.
• Elevate disease state education to external experts, prescribers, advocacy groups, and patients
• Develop Key Opinion Leader (KOL) programs, investigator-initiated trials (IITs), and advocacy initiatives
• Allocate resources for CMEs, posters, abstracts, and medical publications
Thought Leader TBA
Acclaim from the 2nd Annual Summit:
“Excellent framework for strategic planning and education of my company stakeholders. Important content to
bring back to my company.”
- Vice President, Medical Scientific Affairs, Ironwood Pharmaceuticals
To register, please visit www.worldcongress.com/biomsl • Phone: 800-767-9499 • Fax: 781-939-2543 • Email: wcreg@worldcongress.com
4. Day One – Wednesday, December 10, 2014 (continued)
2:45 pm –
3:45 pm Open Forum:
Overcome Internal Obstacles and Restricted Resources to Excel in a Saturated Environment
Budget, personnel, and logistics for small to mid-size biotech companies have the potential to restrict scope and impact of medical affairs
organizations. Discuss challenges and opportunities to enhance operations in this open forum. Key topic areas include:
• Evaluate how to develop and grow the Medical Affairs organization to the necessary capacity
• Determine scope of MSL teams and division of field outreach
• Predict and manage field team interactions throughout product lifecycle
• Clearly define roles and responsibilities
• Understand how to operate with KOLs when access is limited
• Manage a remote team successfully
• Communicate and report on the value the team provides
• Understand company expectations on ROI, scientific communication, and education demands
Facilitator:
Kelly Hogan, PharmD
Medical Director, Immunology
Grifols
3:45 pm –
4:15 pm Networking and Refreshment Break
4:15 pm –
5:00 pm Panel DISCUSSION:
Evaluate Quality Metrics to Prove Value to Internal Stakeholders
Medical Affairs organizations have the continuous obstacle of assessing, measuring, and communicating department value to internal
stakeholders. Discuss methods and opportunities to assess value:
• Educate senior management and internal stakeholders
• Increase cross-company communication and collaboration
• Align the Medical Affairs organization to maximize the contribution and benefit to the company
• Position Medical Affairs and field teams in the context of company strategy for a heightened perceived value
Nicole H. Longwell, PhD
National Director, Medical Science Liaisons, Autoimmune and Rare Diseases Business
Mallinckrodt
Additional Panelists TBA
5:00 pm –
5:45 pm Benchmark KOL Development Opportunities in a Restricted Environment
With a delicate balancing act between access, reach, and impact of external experts, medical affairs organizations can maximize outreach
by focusing on their ability to:
• Identify external experts and touchpoints at a local, regional, and global level
• Translate field information internally to be leveraged for success
• Grow a network of KOLs through alliances and relationship development
Thomas Hitchcock, PhD
Associate Director, Department of Clinical and Medical Affairs
Ulthera, Inc.
Noam Frey, MD, MBA
Vice President, North American Medical Affairs
InterMune (Tentative)
5:45 pm –
6:45 pm Cocktail and Networking Reception
Acclaim from the 2nd Annual Summit:
“The conference was a great mix of ideas and topics. The attendees were engaged and that led to great
discussions all around. World Congress conferences are always well thought out and include very dynamic
speakers. I always walk away from the conference having learned so much more than I expected.”
- Director of Operations, Cutting Edge Information
To register, please visit www.worldcongress.com/biomsl • Phone: 800-767-9499 • Fax: 781-939-2543 • Email: wcreg@worldcongress.com
5. Day Two – Thursday, December 11, 2014
8:00 am –
8:30 am Morning Coffee
8:30 am –
8:45 am Chairperson’s Welcome and Review of Day One
Sean Turbeville, PhD
Senior Director, Medical and Scientific Affairs
Sunesis (Tentative)
8:45 am –
9:30 am Accelerate Access through Advanced Health Outcomes Strategy and Innovation
• Leverage outcomes to demonstrate how products can deliver value to patients with unmet medical needs
• Identify metrics, transformative processes, and technology applications to drive delivery and acceleration of therapy to leverage
technology for accelerated development
• Assess the evolving roles of the MSL — Health Outcome and PharmacoEconomic (HOPE) Liaisons, Clinical Trial Liaisons, HEOR
Liaisons, and Managed Care Liaisons
Stuart H. Levine, MD, MHA
Executive Vice President, Heritage Provider Network
Assistant Professor, Internal Medicine and Psychiatry, David Geffen School of Medicine, UCLA
9:30 am –
10:15 am Go Global — Develop a Global Medical Affairs Presence
Making the determination to expand a global field force and presence requires a needs and capabilities assessment. In this session:
• Evaluate timeline impact to determine the right opportunities and environments to expand a global field force
• Examine when to place field teams abroad and assess timing of engagement
• Determine engagement with European MSLs, KOLs, and stakeholders
• Assess needs for a European partner for success and promotion
Richey Neuman, MD, MPH
Vice President, Medical Affairs
Hyperion Therapeutics
10:15 am –
10:45 am Networking and Refreshment Break
10:45 am –
11:30 am Case Study: MSL Lifecycle Management for an Orphan Drug
Assess the role the medical affairs organization plays in product development, clinical trials, and commercialization. Hear a real-world
example for success, including how to:
• Alter the medical affairs model to have a long-term focus on innovation while delivering value to patients with unmet medical needs
• Adhere to the drug development cycle for orphan and innovative therapies while identifying possible early access opportunities
• Incorporate patient-centric focus on product for realistic forecast
Dennis L. Decktor, PhD MBA
Senior Medical Director, Sarilumab
Lead, Medical Affairs, Regeneron
11:30 am –
12:15 pm Roundtable discussion: Medical Affairs Planning through the Product Lifecycle
Determine the level of internal and external engagement needed during each phase. Benchmark where others are focusing their teams
during development. Discuss:
• Reporting structure and methodology
• Scope and capacity of reach for Medical Affairs teams
• Commercial access to product on market
• Compliance limitations and regulations
Facilitator:
William Soliman, PhD
Medical Director, Metabolic Diseases, Specialty Care, Medical Affairs Group
Eisai, Inc.
12:15 pm –
1:30 pm Luncheon
To register, please visit www.worldcongress.com/biomsl • Phone: 800-767-9499 • Fax: 781-939-2543 • Email: wcreg@worldcongress.com
6. Day Two – Thursday, December 11, 2014 (continued)
1:30 pm –
2:15 pm Ensure Compliance with Scientific Exchange and Off-Label Promotion when Partnering
with External Partners
• Meet compliance regulations when partnering with a company subject to differing restrictions
• Understand the boundaries of compliance issues when working in orphan indications
• Evaluate when to rely on compendia listing for drug usage
• Leverage disease state education to identify opportunities and limitations with partner
Peter Lee, JD, LLM
Senior Director, Health Care Compliance
Pharmacyclics
2:15 pm –
3:00 pm How to Pick a Partner — Best Practices for External Scientific Collaboration
With declining availability of federal funds, biotech companies are increasing their outreach to partner with larger firms and research
universities. Assess medical affairs’ role in the relationship to collaborate and share funding with academia:
• Assess the scientific expertise of the potential external partners
• Align quality metrics to meet institution needs for reducing readmissions
• Determine appropriate relationship guidelines when partnering with investigators
• Sync up clinical development timelines to ensure success in operating under different government structures, data review processes,
and decision making deadlines
• Balance needs, demands, and intellectual property rights to ensure a successful business model
Thought Leader TBA
3:00 pm Close of Summit
WHY YOU SHOULD SPONSOR
POSITION
your company
as a leading
solutions and
service provider
MEET
your market
SHOWCASE
new technology
innovations
INCREASE
brand awareness
GENERATE
leads and new
business
DEVELOP
new and
current client
relationships
Benefit from one-on-one meetings, corporate branding and relationship
building by participating as an active corporate supporter and sponsor.
To inquire about sponsorship and executive networking opportunities, contact:
David Capobianco, Vice President, Business Development, World Congress
781-939-2635 | David.Capobianco@worldcongress.com
To register, please visit www.worldcongress.com/biomsl • Phone: 800-767-9499 • Fax: 781-939-2543 • Email: wcreg@worldcongress.com
7. Space is limited – Register today to secure the best possible rate!
Call: 800-767-9499 | Email: wcreg@worldcongress.com | Visit: www.worldcongress.com/biomsl
Venue:
Hilton San Diego Resort & Spa
1775 E Mission Bay Drive, San Diego, CA 92109
619-276-4010
sandiegohilton.com
Discounted Room Rate: $149
Please mention WC Research/World Congress
when registering to receive this special rate!
World Congress
500 West Cummings Park, Suite 5200
Woburn, MA 01801
PB14020
wcreg@worldcongress.com
PHONE
800-767-9499
781-939-2400 outside the U.S.
ATTN Mail Room: If undeliverable please forward to Medical and Clinical
Affairs Departments
@wrldhealthcare
#biomsl
PRSRT STD
U.S. Postage
PAID
Gallery
Registration Fee: Register By
PHARMA / BIOTECH / 9/26/2014
12/10/2014
device
Conference $1595.00 $1695.00 $1895.00
Conference + Workshop $1895.00 $1995.00 $2195.00
STANDARD
Conference $1895.00 $1995.00 $2195.00
Conference + Workshop $2195.00 $2295.00 $2495.00
Fee for conference includes welcome coffee, lunch, reception,
refreshments, and web-based conference documentation available
pre- and post-event, accessible through password-protected website.
Checks in U.S. funds drawn from U.S. bank payable to: WC Research Inc.
No personal checks accepted. Verification may be required for rate
approvals. Please contact us should you have any special needs.
SPECIAL TEAM DISCOUNTS: Your organization may
send ONE executive FREE for every three delegates
registered. All registrations must be made at the same
time to qualify. To register your team, contact us at 800-767-9499.
Participant Substitution and Cancellations:
Your registration may be transferred to a member of your organization
up to 24 hours in advance of the conference. Cancellations received
in writing on or before 30 days prior to the start of the event will be
refunded, less a $395 administrative charge. No refunds will be
made after this date; however, the registration fee less the $395
administrative charge can be credited to another World Congress
conference if you register within 6 months from the date of this
conference. In case of conference cancellation, World Congress’
liability is limited to refund of the conference registration fee only.
World Congress reserves the right to alter this program without
prior notice.
Satisfaction guaranteed: World Congress stands behind
the quality of its conferences. If you are not satisfied with the
quality of the conference, a credit will be awarded towards
a comparable World Congress conference of your choice.
Register By
10/17/2014
Register By
Register Now! E-MAIL
WEBSITE
WorldCongress.com/
BioMSL
Best Value
S av e $ 2 0 0 o r m o re b y reg i ster i n g b y Octo ber 1 7 , 2 0 1 4 !
BioPharma World Congress Presents the Third Medical Medical Affairs Summit Affairs
Congress, West Coast
December 10-11, 2014
Ensure Va l u e, Compliance, S u ccess , a n d Growth by Doing More w i t h Less
H i lt o n S an D i e g o R eso rt & S pa • S an D i e g o , C A
Establish a medical
affairs organization
Build high value
medical affairs teams
Msl lifecycle
management
Go global
Msl roles and
evolution
Communicate real
world evidence
Define
compliance
barrier
Target
Demonstrate Value to
Internal stakeholders
MSL quality Metrics:
determine Value
Internal obstacles
development
Enhance the impact of
medical affairs with
limited resources
External
outreach
Engagement
Outreach
The evolving role
of medical affairs
Communication
KOL
Cultivate
Develop
Innovation research
collaboration
External scientific
collaboration
To register, please visit www.worldcongress.com/biomsl • Phone: 800-767-9499 • Fax: 781-939-2543 • Email: wcreg@worldcongress.com